Waters (WAT) Stock Forecast & Price Target

Compare

425 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

WAT Analyst Ratings

Moderate Buy

8 Buy

6 Hold

0 Sell

Based on 14 analysts giving stock ratings to

Waters

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

WAT Stock 12 Month Forecast

Average Price Target

$403.00

▲(24.63% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $403.00 with a high forecast of $480.00 and a low forecast of $330.00. The average price target represents a 24.63% change from the last price of $323.37.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"289":"$289","337":"$337","385":"$385","433":"$433","481":"$481"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":480,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$480.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":403,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$403.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":330,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$330.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[289,337,385,433,481],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,379.31,387.05538461538464,394.8007692307692,402.54615384615386,410.29153846153844,418.0369230769231,425.7823076923077,433.5276923076923,441.2730769230769,449.01846153846157,456.76384615384615,464.5092307692308,472.25461538461536,{"y":480,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,379.31,381.1323076923077,382.9546153846154,384.7769230769231,386.59923076923076,388.4215384615385,390.24384615384616,392.06615384615384,393.8884615384615,395.71076923076924,397.5330769230769,399.3553846153846,401.1776923076923,{"y":403,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,379.31,375.5169230769231,371.7238461538462,367.9307692307692,364.1376923076923,360.3446153846154,356.5515384615385,352.7584615384615,348.9653846153846,345.1723076923077,341.3792307692308,337.5861538461538,333.7930769230769,{"y":330,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":415.48,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":377.34,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":356,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.83,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.31,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":296.48,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.81,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":397.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.83,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":379.31,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$480.00

Average Price Target$403.00

Lowest Price Target$330.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Larew

William Blair

Buy

―

Reiterated

02/17/26

Buy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition

Brandon Couillard

Wells Fargo

$415→$355

Hold

9.78%

Upside

Reiterated

02/11/26

Waters (WAT) Receives a Hold from Wells Fargo

Casey Woodring

J.P. Morgan

$330

Hold

2.05%

Upside

Reiterated

02/11/26

J.P. Morgan Keeps Their Hold Rating on Waters (WAT)

Daniel Brennan

TD Cowen

$400→$373

Hold

15.35%

Upside

Reiterated

02/10/26

Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside

Dan Leonard

UBS

$395→$370

Hold

14.42%

Upside

Reiterated

02/10/26

Waters price target lowered to $370 from $395 at UBSWaters price target lowered to $370 from $395 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$398→$363

Buy

12.26%

Upside

Reiterated

02/10/26

Waters price target lowered to $363 from $398 at BairdWaters price target lowered to $363 from $398 at Baird

Tycho Peterson

Jefferies

$470

Buy

45.34%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: Personalis (NASDAQ: PSNL), Waters (NYSE: WAT) and Alkermes (NASDAQ: ALKS)

Patrick B Donnelly

Citi

$425

Buy

31.43%

Upside

Initiated

02/10/26

Waters resumed with a Buy at CitiWaters resumed with a Buy at Citi

Michael Ryskin

Bank of America Securities

$410→$350

Hold

8.24%

Upside

Reiterated

02/10/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Warby Parker (NYSE: WRBY) and Waters (NYSE: WAT)

Luke Sergott

Barclays

$400

Buy

23.70%

Upside

Initiated

02/10/26

Waters reinstated with an Overweight at BarclaysWaters reinstated with an Overweight at Barclays

Subbu Nambi

Guggenheim

$440

Buy

36.07%

Upside

Reiterated

02/09/26

Analysts' Top Healthcare Picks: Haemonetics (HAE), Waters (WAT)

Sidharth Sahoo

HSBC

$460

Buy

42.25%

Upside

Initiated

01/27/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Waters (NYSE: WAT)

Doug Schenkel

Wolfe Research

$480

Buy

48.44%

Upside

Upgraded

12/10/25

Waters upgraded to Outperform from Peer Perform at Wolfe ResearchWaters upgraded to Outperform from Peer Perform at Wolfe Research

Kallum Titchmarsh

Morgan Stanley

$423

Hold

30.81%

Upside

Initiated

12/01/25

Waters initiated with an Equal Weight at Morgan StanleyWaters initiated with an Equal Weight at Morgan Stanley

Daniel Arias

Stifel Nicolaus

$360→$380

Hold

17.51%

Upside

Reiterated

11/05/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Waters (NYSE: WAT), Henry Schein (NASDAQ: HSIC) and Supernus Pharmaceuticals (NASDAQ: SUPN)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Larew

William Blair

Buy

―

Reiterated

02/17/26

Buy Rating Reaffirmed on Temporary Headwinds and Credible Turnaround Path Post-BD Acquisition

Brandon Couillard

Wells Fargo

$415→$355

Hold

9.78%

Upside

Reiterated

02/11/26

Waters (WAT) Receives a Hold from Wells Fargo

Casey Woodring

J.P. Morgan

$330

Hold

2.05%

Upside

Reiterated

02/11/26

J.P. Morgan Keeps Their Hold Rating on Waters (WAT)

Daniel Brennan

TD Cowen

$400→$373

Hold

15.35%

Upside

Reiterated

02/10/26

Maintaining Hold on Waters as BD Life Sciences Weakness and Reduced Premium Valuation Temper Near‑Term Upside

Dan Leonard

UBS

$395→$370

Hold

14.42%

Upside

Reiterated

02/10/26

Waters price target lowered to $370 from $395 at UBSWaters price target lowered to $370 from $395 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$398→$363

Buy

12.26%

Upside

Reiterated

02/10/26

Waters price target lowered to $363 from $398 at BairdWaters price target lowered to $363 from $398 at Baird

Tycho Peterson

Jefferies

$470

Buy

45.34%

Upside

Reiterated

02/10/26

Analysts Offer Insights on Healthcare Companies: Personalis (NASDAQ: PSNL), Waters (NYSE: WAT) and Alkermes (NASDAQ: ALKS)

Patrick B Donnelly

Citi

$425

Buy

31.43%

Upside

Initiated

02/10/26

Waters resumed with a Buy at CitiWaters resumed with a Buy at Citi

Michael Ryskin

Bank of America Securities

$410→$350

Hold

8.24%

Upside

Reiterated

02/10/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Warby Parker (NYSE: WRBY) and Waters (NYSE: WAT)

Luke Sergott

Barclays

$400

Buy

23.70%

Upside

Initiated

02/10/26

Waters reinstated with an Overweight at BarclaysWaters reinstated with an Overweight at Barclays

Subbu Nambi

Guggenheim

$440

Buy

36.07%

Upside

Reiterated

02/09/26

Analysts' Top Healthcare Picks: Haemonetics (HAE), Waters (WAT)

Sidharth Sahoo

HSBC

$460

Buy

42.25%

Upside

Initiated

01/27/26

Analysts Offer Insights on Healthcare Companies: Merck & Company (NYSE: MRK) and Waters (NYSE: WAT)

Doug Schenkel

Wolfe Research

$480

Buy

48.44%

Upside

Upgraded

12/10/25

Waters upgraded to Outperform from Peer Perform at Wolfe ResearchWaters upgraded to Outperform from Peer Perform at Wolfe Research

Kallum Titchmarsh

Morgan Stanley

$423

Hold

30.81%

Upside

Initiated

12/01/25

Waters initiated with an Equal Weight at Morgan StanleyWaters initiated with an Equal Weight at Morgan Stanley

Daniel Arias

Stifel Nicolaus

$360→$380

Hold

17.51%

Upside

Reiterated

11/05/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Waters (NYSE: WAT), Henry Schein (NASDAQ: HSIC) and Supernus Pharmaceuticals (NASDAQ: SUPN)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Waters

3 Months

xxx

Success Rate

9/13 ratings generated profit

Average Return

+4.78%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +4.78% per trade.

1 Year

Catherine Ramsey SchulteRobert W. Baird

Success Rate

8/13 ratings generated profit

Average Return

+9.54%

a rating ―

Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +9.54% per trade.

2 Years

xxx

Success Rate

10/13 ratings generated profit

Average Return

+14.13%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +14.13% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WAT Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, WAT has received 14 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. WAT average Analyst price target in the past 3 months is 403.00.

Each month's total comprises the sum of three months' worth of ratings.

WAT Financial Forecast

WAT Earnings Forecast

Next quarter’s earnings estimate for WAT is $2.35 with a range of $2.27 to $2.55. The previous quarter’s EPS was $4.53. WAT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Sales Forecast

Next quarter’s sales forecast for WAT is $1.16B with a range of $706.54M to $1.52B. The previous quarter’s sales results were $932.36M. WAT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year WAT has Performed in-line its overall industry.

WAT Stock Forecast FAQ

What is WAT’s average 12-month price target, according to analysts?

Based on analyst ratings, Waters Corp’s 12-month average price target is 403.00.

What is WAT’s upside potential, based on the analysts’ average price target?

Waters Corp has 24.63% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is WAT a Buy, Sell or Hold?

Waters Corp has a consensus rating of Moderate Buy which is based on 8 buy ratings, 6 hold ratings and 0 sell ratings.

What is Waters Corp’s price target?

The average price target for Waters Corp is 403.00. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $480.00 ,the lowest forecast is $330.00. The average price target represents 24.63% Increase from the current price of $323.37.

What do analysts say about Waters Corp?

Waters Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of WAT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Waters (WAT) Stock Forecast & Price Target

WAT Analyst Ratings

WAT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Waters

WAT Analyst Recommendation Trends

WAT Financial Forecast

WAT Earnings Forecast

WAT Sales Forecast

WAT Stock Forecast FAQ

Detailed List of Analyst Forecasts